$84.99
Research Studies:
Blend Specification:
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
CJC-1295 No DAC + Ipamorelin (10mg Blend) is a research-use-only peptide blend supplied for controlled laboratory workflows, multi-compound documentation review, and analytical characterization. This blend is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
CJC-1295 No DAC + Ipamorelin (10mg Blend) is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | CJC-1295 NO DAC: 863288-34-0 |
|---|---|
| Sequence | CJC-1295 NO DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Gln-Arg-Gly-Ala-Gln-Gly Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
| Molecular Formula | Varies (peptide blend) |
| Molecular Weight | CJC-1295 NO DAC: 3367.96 g/mol, Ipamorelin: 711.91 g/mol |
| Applications | Growth hormone research, muscle regeneration studies, metabolic function research |
| Purity | ≥99% |
| Synthesis | Solid-phase synthesis |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy CJC-1295 No DAC+Ipamorelin Blend online should evaluate this material as research procurement, not as a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how qualified research teams can evaluate CJC-1295 No DAC+Ipamorelin 10mg Blend through Pure Lab Peptides while keeping the discussion limited to research-use-only documentation and supplier review.
Researchers can buy CJC-1295 No DAC+Ipamorelin Blend online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase `buy CJC-1295 No DAC+Ipamorelin Blend online` is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the search is about whether a research-use-only material is documented clearly enough for a qualified laboratory buyer, technical procurement team, or research institution to evaluate it before purchase.
Research procurement is different from consumer shopping. A laboratory buyer should look for RUO labeling, lot-level traceability, batch-specific documentation, product-form consistency, storage information, and supplier language that avoids therapeutic, diagnostic, veterinary, or personal-use positioning. FDA materials on RUO and IUO labeling for in vitro diagnostic products emphasize that research labeling must be tied to research intent rather than diagnostic representation, and 21 CFR 809.10 describes the statement used for certain research-phase laboratory products in the IVD context.[1] [2]
A strong procurement record should be specific enough for another laboratory reviewer to understand what was ordered, which lot was received, and which documents supported acceptance into the research inventory. That record may include the supplier name, product display name, lot number, COA identifier, stated product form, storage note, and date of documentation review. For peptide blends, the record should also clarify that the material is a blend and that the review was based on supplier documentation rather than assumptions drawn from single-component literature.
For CJC-1295 No DAC+Ipamorelin Blend research-use-only sourcing, the buying decision should center on documentation. Researchers should confirm that the product name, lot number, stated form, and CJC-1295 No DAC+Ipamorelin Blend COA align. They should also review whether the supplier presents the blend as a laboratory research material rather than a product for human or animal application.
CJC-1295 No DAC+Ipamorelin Blend is best described, for procurement purposes, as a two-component peptide blend intended for controlled laboratory research. Public chemical databases list CJC1295 without DAC as a peptide compound record and list ipamorelin as a defined peptide compound record.[3] [4] The product display name from Pure Lab Peptides is CJC-1295 No DAC+Ipamorelin 10mg Blend, supplied as lyophilized powder with a stated ≥99% purity claim and batch-specific COA availability.
The word “blend” matters for documentation. A single-component peptide record can focus on one compound identity, while a blend record must support the listed composition as a combined research material. Procurement teams should therefore look for CJC-1295 No DAC+Ipamorelin Blend identity testing that is appropriate to the product description, and they should confirm that the COA and product page use consistent naming. When documentation is unclear, the appropriate procurement response is to request clarification before relying on the material for laboratory planning.
Published scientific context for the two components is pathway-oriented. GHRHR is identified by UniProt as a receptor for growth-hormone-releasing factor, and GHSR is identified as a ghrelin-associated G-protein-coupled receptor.[5] [6] This receptor terminology is included only to describe research classification. It is not a product-use claim, and it should not be converted into expected outcomes for any RUO material.
The CJC-1295 literature includes work on hGRF(1-29) analog design and albumin-binding approaches. A 2005 Endocrinology paper identified CJC-1295 as a long-lasting GRF analog in a research model.[7] Product names that include “No DAC” should therefore be read carefully: procurement teams should not assume that every CJC-1295 article applies directly to a no-DAC material, and they should rely on the product page and batch-specific documentation for identity review.
Ipamorelin appears in peptide-secretagogue literature as a pentapeptide, and review literature discusses ghrelin receptor ligands as a broader research class.[8] [9] For this article, those sources are scientific context only. Blend composition should be evaluated through documentation and identity review, not expected outcomes or use protocols.
Researchers search “buy CJC-1295 No DAC+Ipamorelin Blend online” to compare RUO availability, product documentation, identity testing, purity data, COA access, lot number matching, supplier transparency, and product form. The search phrase may look commercial, but on this page it is treated as a research-procurement query for qualified laboratory buyers.
A procurement team may need a CJC-1295 No DAC+Ipamorelin Blend research material for compound characterization, assay development planning, reference comparison, or other controlled laboratory workflows. Before they buy CJC-1295 No DAC+Ipamorelin Blend, the team should ask whether the supplier provides clear RUO labeling, whether the COA is batch-specific, whether the stated material is a lyophilized powder, and whether the documentation connects to the same lot that will be received.
Different laboratory roles may review the same source from different angles. A scientific lead may focus on compound identity and research category, a procurement specialist may focus on supplier records and order traceability, and a quality reviewer may focus on whether the COA, label, and internal inventory entry all match. A useful online listing supports each of those roles without drifting into use instructions or outcome language.
Supplier language is also part of the quality review. A research-use-only supplier should describe identity, purity, analytical documentation, storage information, and traceability. It should not position the material for personal use, clinical use, veterinary use, diagnostic use, or outcome-based claims. This distinction is especially important for peptide blends because a blend name can tempt readers to focus on combined expectations rather than documentation. For RUO procurement, the responsible approach is to review the CJC-1295 No DAC+Ipamorelin Blend supplier documentation and keep the evaluation anchored to laboratory records.
Qualified researchers evaluating where to buy CJC-1295 No DAC+Ipamorelin Blend online should prioritize documentation over promotional language. The following table summarizes procurement signals that help separate RUO research sourcing from non-compliant consumer positioning.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
A useful CJC-1295 No DAC+Ipamorelin Blend COA should connect the documented lot to the material received by the laboratory. Researchers should review the compound name, lot number, test date, purity percentage, test method, identity confirmation, product form, and any chromatographic or mass data included in the batch-specific record. FDA analytical-method guidance discusses analytical procedures in relation to identity, quality, purity, and potency documentation, while ICH Q2(R2) and ICH Q14 describe principles for analytical validation and analytical procedure development.[10] [11] [12]
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. This is especially important for peptide materials because analytical literature describes peptide-related impurities, structurally related peptide impurity assessment, and LC-HRMS approaches for peptide quality control.[13] [14] [15] Reference-standard literature for synthetic peptides also emphasizes vialing, lyophilization, analytical testing, and stability studies as part of a broader quality framework.[16]
For a blend, documentation review should consider both blend-level naming and component-level identity. Researchers should not rely on the product name alone. CJC-1295 No DAC+Ipamorelin Blend identity testing is stronger when the COA, label, product page, and laboratory records all support the same material description.
For CJC-1295 No DAC+Ipamorelin Blend, the documentation package should be read as a set. The product page identifies the catalog-level material, the label identifies what the laboratory receives, the COA records batch-level analytical information, and internal laboratory records capture the acceptance decision. Any mismatch among those records can create uncertainty about the material identity. Researchers should preserve documentation in a way that allows later review without depending on memory or informal supplier claims.
Published literature mentions the CJC-1295 and ipamorelin components in GHRH-pathway, secretagogue-receptor, pharmacokinetic, pharmacodynamic, and analytical-detection contexts. That literature is useful for research classification, but it does not replace lot-specific supplier documentation and it does not create product-use guidance for a research-use-only material.
The evidence landscape is uneven because some publications focus on analog chemistry, some on receptor or pathway models, some on human clinical study settings, and others on analytical detection. None of those evidence types is the same as a COA for the specific lot being procured. Literature can inform terminology and research background, but lot-specific identity and purity review must come from current supplier documentation and laboratory records.
CJC-1295 publications include human-study literature on a long-acting GHRH analog, work on pulsatile secretion during continuous stimulation, preclinical model literature, and proteomic analysis in research settings.[17] [18] [19] [20] Those studies are outside the scope of Pure Lab Peptides RUO product use. Published clinical literature should not be interpreted as use guidance for RUO materials.
Ipamorelin publications include a pharmacokinetic-pharmacodynamic study in volunteers and earlier peptide-secretagogue characterization, while broader ghrelin-receptor reviews describe ligand classes and receptor-focused drug discovery research.[21] [8] [22] Research teams should not translate those studies into dosing, administration, therapeutic, wellness, or performance claims for CJC-1295 No DAC+Ipamorelin Blend research-use-only material.
Analytical literature has also described screening and confirmation approaches for CJC-1295 and related analogs, which reinforces the broader point that peptide identity can require method-specific evidence rather than name-based assumption.[23] Pathway relevance in published literature does not establish product-use guidance for RUO materials. Blend composition should be evaluated through documentation and identity review, not expected outcomes or use protocols.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, or classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | Relevant receptor, pathway, biochemical class, or model-specific research area | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “CJC-1295 No DAC+Ipamorelin Blend is discussed in published research related to peptide pathway and secretagogue-receptor context.” | Describes literature context without making a product claim | “CJC-1295 No DAC+Ipamorelin Blend helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy CJC-1295 No DAC+Ipamorelin Blend for results.” |
| “Pure Lab Peptides supplies CJC-1295 No DAC+Ipamorelin Blend as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies CJC-1295 No DAC+Ipamorelin Blend for therapy.” |
| “The phrase buy CJC-1295 No DAC+Ipamorelin Blend online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy CJC-1295 No DAC+Ipamorelin Blend online for personal use.” |
| “Blend composition should be checked through supplier documentation and analytical identity review.” | Keeps attention on documented composition | “The blend should be selected for combined effects.” |
Pure Lab Peptides presents CJC-1295 No DAC+Ipamorelin 10mg Blend as a research-use-only material. The product is supplied as lyophilized powder, carries a ≥99% purity claim, and has a batch-specific COA available for documentation review. Laboratory buyers should review the product page, the COA, the product label, storage and handling documentation, and any lot-level traceability information before adding the material to research procurement records.
Because the COA is available, researchers should review it in present tense as part of procurement due diligence. The review should not be conditional or informal. A laboratory buyer can compare the COA to the product page, confirm that the listed material is CJC-1295 No DAC+Ipamorelin 10mg Blend, and document the stated purity claim, product form, and lot-level information in internal records.
Review the Pure Lab Peptides CJC-1295 No DAC+Ipamorelin Blend research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation. Researchers comparing related laboratory materials can also review the Pure Lab Peptides research peptide collection. The important procurement question is not whether a product page sounds persuasive; it is whether the CJC-1295 No DAC+Ipamorelin Blend purity documentation, identity information, COA, product form, storage details, and supplier transparency support controlled laboratory recordkeeping.
Buy CJC-1295 No DAC+Ipamorelin Blend online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, lot traceability, and supplier transparency.
Published literature may describe receptor systems, peptide analogs, model-based findings, or analytical methods. That literature should not be translated into guidance for RUO materials. A CJC-1295 No DAC+Ipamorelin Blend research material should be evaluated through documentation, not through clinical, wellness, or outcome-based assumptions.
A purity percentage is only one data point. Researchers should review the analytical method, identity evidence, lot number, product name, and COA consistency together. For peptide blends, identity review should account for the component naming and the blend-level documentation rather than relying only on a headline purity claim.
COA documentation is most useful when it is batch-specific and tied to the lot received by the laboratory. A general specification sheet cannot replace lot-level documentation. Procurement records should connect the CJC-1295 No DAC+Ipamorelin Blend COA, label, and product page to the same research material.
RUO labeling does not support human use, animal use, clinical use, diagnostic use, veterinary use, or consumer use. It narrows the intended context to controlled laboratory research. Qualified buyers should confirm that supplier language remains consistent with the research-use-only label.
Supplier transparency is valuable only when it is supported by documentation. Researchers should look for CJC-1295 No DAC+Ipamorelin Blend supplier documentation that includes COA access, purity information, identity testing, lot traceability, product form, and storage information. Claims without documentation should not drive procurement decisions.
Researchers can buy CJC-1295 No DAC+Ipamorelin Blend online for laboratory research from an RUO supplier that provides clear labeling, batch-specific COA documentation, purity information, identity review materials, storage details, and lot-level traceability. Pure Lab Peptides provides a product page for qualified research procurement review.
Before buying CJC-1295 No DAC+Ipamorelin Blend online, researchers should check RUO labeling, the batch-specific COA, product-form description, stated purity, identity testing method, lot number consistency, supplier documentation, and storage information. The review should remain focused on laboratory procurement rather than any personal-use interpretation.
A COA matters when buying CJC-1295 No DAC+Ipamorelin Blend because it connects the research material to batch-specific documentation. Researchers should use the COA to review purity, identity, test method, lot number, and product-name consistency. The COA should be read with the label and product page.
CJC-1295 No DAC+Ipamorelin Blend is not intended for human or animal consumption. In this article, the material is discussed only as a research-use-only compound for laboratory procurement review. It is not presented for clinical, diagnostic, veterinary, personal, therapeutic, wellness, or consumer use.
Research use only means CJC-1295 No DAC+Ipamorelin Blend should be evaluated as a laboratory research material. The procurement focus is documentation: RUO labeling, batch-specific COA availability, purity support, identity testing, lot traceability, supplier transparency, and storage information. RUO language does not create permission for non-research use.
Published literature about the components of CJC-1295 No DAC+Ipamorelin Blend should be interpreted as scientific context, not as product-use guidance. Researchers may use literature to understand classification, analytical methods, or receptor-pathway terminology, while keeping procurement decisions anchored to current RUO documentation.
Qualified researchers evaluating CJC-1295 No DAC+Ipamorelin Blend should review product labeling, COA status, identity documentation, storage information, and supplier transparency. Review the CJC-1295 No DAC+Ipamorelin Blend product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.